| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.933 | 11.463 | 8.174 | 20.259 | 20.016 | 14.915 | 20.230 | 14.473 | 6.829 | 15.655 |
| Total Income - EUR | 10.945 | 17.853 | 8.393 | 20.259 | 20.016 | 14.915 | 20.230 | 14.473 | 6.829 | 15.655 |
| Total Expenses - EUR | 9.142 | 18.015 | 14.282 | 18.841 | 14.935 | 6.928 | 15.607 | 11.998 | 11.329 | 12.645 |
| Gross Profit/Loss - EUR | 1.804 | -162 | -5.890 | 1.418 | 5.081 | 7.986 | 4.623 | 2.475 | -4.500 | 3.010 |
| Net Profit/Loss - EUR | 1.475 | -340 | -5.974 | 1.215 | 4.881 | 7.887 | 4.569 | 2.285 | -4.565 | 2.854 |
| Employees | 2 | 2 | 2 | 3 | 3 | 1 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Valexil-Ionis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.813 | 1.754 | 4.757 | 3.976 | 3.274 | 2.489 | 1.780 | 1.130 | 474 | 60 |
| Current Assets | 2.507 | 3.978 | 1.935 | 3.974 | 1.423 | 6.438 | 10.223 | 9.009 | 1.923 | 5.542 |
| Inventories | 992 | 982 | 965 | 947 | 913 | 895 | 876 | 878 | 876 | 0 |
| Receivables | 83 | 83 | 81 | 80 | 79 | 77 | 87 | 1.825 | 215 | 0 |
| Cash | 1.431 | 2.914 | 888 | 2.947 | 432 | 5.466 | 9.261 | 6.306 | 833 | 5.542 |
| Shareholders Funds | 3.512 | -287 | -5.709 | -4.389 | 577 | 8.453 | 10.813 | 8.549 | 1.680 | 4.524 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 808 | 6.019 | 12.401 | 12.338 | 4.121 | 474 | 1.191 | 1.591 | 718 | 1.078 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9531 - 9531" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Valexil-Ionis Srl